Introduction {#s1}
============

Disulfide bonds have a critical role in stabilizing correctly folded secreted and membrane proteins ([@bib8]). Dedicated enzymatic machinery, consisting of disulfide exchange catalysts of the protein disulfide isomerase (PDI) class, rapidly introduces disulfide bonds into nascent polypeptide chains. The recycling of PDIs back to their oxidized form is mediated by upstream oxidases, exemplified by ERO1 and back-up enzymes, such as PRDX4 and VKOR that exploit O~2~, H~2~O~2~, and vitamin K epoxide, respectively, as downstream electron acceptors. Defects in components of this electron transfer chain markedly affect protein folding homeostasis in the ER ([@bib32]; [@bib30]; [@bib38]).

Many disulfides introduced by the oxidative machinery are not native and must be broken down in an editing process that is catalyzed by reduced forms of PDIs ([@bib15]). This editing entails attack by the reduced N-terminal cysteine of PDI\'s active site on the misplaced disulfide following resolution of the mixed disulfide. The latter proceeds either by way of a zero-sum re-shuffling process entailing an attacking second reduced cysteine in the client polypeptide, which releases reduced PDI and establishes a new disulfide, or by a net reductive process involving an attack on the mixed disulfide by the C-terminal active site cysteine, in which PDI 'escapes' in its oxidized form, having reduced its client protein ([@bib37]). Both mechanisms require a pool of reduced PDI, the maintenance of which is not trivial, given the oxidative environment in the ER. This challenge is especially great in case of the second mechanism, which is a set-up for iterative cycles of net oxidation-reduction-oxidation ([@bib31]).

The crucial role of reduced PDI to oxidative protein folding is supported by in vitro experiments in which PDI\'s ability to accelerate folding is not monotonically increased by its oxidized fraction, but rather is optimal in a redox buffer that also contains a high concentration of reduced glutathione ([@bib24]). Yeast genetics reveal that disulfide shuffling (which requires reduced PDI) is *PDI1*\'s essential function, as an active-site mutant that has lost the ability to produce disulfides (but has selectively retained activity as a disulfide reductase) is nonetheless able to rescue the lethal phenotype of *pdi1* nullizygosity ([@bib22]).

The reductive facet of oxidative protein folding in the ER is especially important to the maturation of large proteins such as the low density lipoprotein receptor (LDL-R), in which it has been estimated that most disulfides that form early during biogenesis are non-native and must be rearranged before the protein clears ER quality control and traffics to the Golgi ([@bib17]). This editing process appears to involve a specific PDI family member, ERdj5 ([@bib28]). ERdj5 may have specialized in disulfide reduction, as its redox function also accelerates the clearance of misfolded ER proteins such as the null Hong Kong mutant α1-antitrypsin (NHK-A1AT) ([@bib36]; [@bib12]), but the identity of ERdj5\'s reductase remains unknown.

Reductive editing of disulfides is also observed in the *E. coli* periplasm. Where the transfer of electrons from reduced thioredoxin in the cytosol maintains a reduced pool of the periplasmic isomerases, DsbC and DsbG. Electrons are conveyed across the inner-membrane space by a specialized transmembrane protein DsbD. This protein relay-based mechanism enables DsbC/DsbG-dependent disulfide shuffling despite the absence of a soluble small molecule redox buffer in the periplasmic space of gram negative bacteria (reviewed in [@bib6]). By contrast, the mammalian ER contains up to 15 mM glutathione ([@bib26]) whose reduced form is widely believed to fuel the reductive aspects of secreted protein metabolism in eukaryotes, by serving as a terminal electron donor to reduce PDI family members (reviewed in [@bib19]).

To critically examine the role of ER glutathione in the reductive re-shuffling of non-native disulfides and in the reductive steps believed to be associated with degradation of misfolded ER proteins, we devised a method to selectively deplete the ER of glutathione and examined the consequences on the organelles\' capacity to handle well-characterized sentinel proteins.

Results {#s2}
=======

A glutathione-degrading enzyme suited to the oxidizing conditions of the endoplasmic reticulum {#s2-1}
----------------------------------------------------------------------------------------------

Kumar et al. recently reported that the mammalian pro-apoptotic gene *ChaC1* encodes a glutathione-specific γ-glutamyl cyclotransferase that efficiently degrades glutathione ([@bib20]). We confirmed their observations by measuring the ability of purified murine ChaC1 (expressed in *E. coli*) to degrade glutathione in vitro: At submicromolar enzyme concentrations, recombinant ChaC1 was able to degrade a 10 mM solution of reduced glutathione within 1 hr ([Figure 1A](#fig1){ref-type="fig"}). The enzymatic activity was selective towards reduced glutathione (GSH) ([Figure 1B](#fig1){ref-type="fig"}). The inability of oxidized glutathione (GSSG) to serve as a substrate for degradation correlated with its inability to bind a Chac1-based optical probe whose fluorescent resonance energy transfer (FRET) signal reflects substrate binding ([Figure 1C--D](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). An E116Q mutation abolished all enzymatic activity ([Figure 1E](#fig1){ref-type="fig"}), as observed previously ([@bib20]).10.7554/eLife.03421.003Figure 1.ChaC1 efficiently and selectively degrades reduced glutathione.(**A**) A bar-graph representation of residual glutathione levels following incubation of 10 mM glutathione with the indicated concentrations of bacterially expressed mouse ChaC1. Varying concentrations of enzymes were assayed at a single time point (left panel) and varying initial concentrations of glutathione were assayed at different time points (right panel). (**B**) Comparison of the ability of ChaC1 to eliminate reduced (GSH) and oxidized glutathione (GSSG). Note that ChaC1 effectively eliminated reduced glutathione, but had no effect on oxidized glutathione. (**C**) Cartoon of the fluorescent resonance energy transfer (FRET) probe, OG-ChaC1-Cherry, used to detect substrate binding to ChaC1. Shown is a model of murine ChaC1 (UniProt Q8R3J5) residues 31--204, created by Phyre^2^ ([@bib18]) based on the crystal structure of γ-glutamyl cyclotransferase (PDB 2RBH). The side chain of Cys 92, which has been modified with the Oregon Green (OG) donor, is highlighted, as is the C-terminus of the protein, site of the fused mCherry fluorescent acceptor. (**D**) Time-resolved FRET signal (expressed as the ratio of the emission signal at 532 nm and 670 nm upon excitation at 480 nm) of the OG-ChaC1-Cherry probe \[2.5 µM\] following exposure to 10 mM reduced (GSH) or oxidized glutathione(GSSG). Where indicated, the sample was injected with dithiotreitol (DTT) to reduce the GSSG and convert it to a substrate for ChaC1. The biphasic change in FRET signal upon exposure to GSH is consistent with binding followed by breakdown of GSH by the probe, which retains its enzymatic activity. (**E**) Comparison of glutathione elimination by purified bacterially expressed wild-type and E116Q mutant ChaC1 in vitro.**DOI:** [http://dx.doi.org/10.7554/eLife.03421.003](10.7554/eLife.03421.003)10.7554/eLife.03421.004Figure 1---figure supplement 1.Analysis of the substrate binding properties of ChaC1.(**A**) Absorbance spectrum of ChaC1-mCherry, Oregon Green (OG), and Oregon green-labeled ChaC1-mCherry. (**B**) Absorbance profile of size-exclusion chromatogram of Oregon green-labeled ChaC1 mCherry. Note the coincidence of the absorption peak for protein (280 nm), Oregon Green (496 nm) and mCherry (587 nm) (**C**) FRET signal of an enzymatically inactive OG-ChaC1^E116Q^-Cherry probe upon exposure to varying concentrations of reduced glutathione. Note the mono-phasic change in FRET signal, consistent with inability of the mutant enzyme to break down glutathione and the contrast with wild-type OG-ChaC1-mCherry ([Figure 1D](#fig1){ref-type="fig"}). (**D**) Graph of the relationship between the steady-state FRET signal of the OG-ChaC1^E116Q^-Cherry probe and the concentration of reduced glutathione (GSH).**DOI:** [http://dx.doi.org/10.7554/eLife.03421.004](10.7554/eLife.03421.004)

To exploit ChaC1 as a tool to purge the ER of glutathione, we targeted expression of this cytosolic enzyme to the ER, by fusing the coding sequence to an N-terminal cleavable signal peptide and a C-terminal KDEL ER retention signal. An N-terminal FLAG-M1 peptide tag was included, to facilitate detection of the enzyme. Cells transfected with a plasmid encoding ER-FLAG-ChaC1 expressed a protein of the expected mobility on reducing SDS-PAGE that reacted with the anti-FLAG antibody ([Figure 2A](#fig2){ref-type="fig"}) and resulted in a granular staining pattern that overlapped with that of the ER marker calreticulin ([Figure 2B](#fig2){ref-type="fig"}). However, unlike cytosolic ChaC1, which migrates at a position expected of the reduced monomer on non-reducing SDS-PAGE ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}), ER-localized ChaC1 migrated as a heterogenous collection of species, consistent with inappropriate disulfide bond formation (compare the reducing and non-reducing SDS-PAGE in [Figure 2A](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}).10.7554/eLife.03421.005Figure 2.Cysteine-free ChaC1 is an active enzyme that can be targeted to the endoplasmic-reticulum.(**A**) Immunoblot of FLAG M1-tagged ER-localized wild type (WT), cysteine-free (CtoS), and compound CtoS; E116Q enzymatically dead ChaC1 in N-ethyl maleimide-blocked lysates of transfected HeLa cells. Lanes 1--4 are from a reducing and lanes 5--8 are from a non-reducing SDS-PAGE. Note the presence of high-molecular weight disulfide linked FLAG-tagged ChaC1 in cells transfected with the WT ER-targeted protein that is absent from those transfected with the cysteine-free, CtoS mutants. (**B**) Fluorescent photomicrographs of HeLa cells transfected with the indicated expression plasmids and immunostained for the FLAG tag (marking ChaC1) and calreticulin (CALR) as an ER marker. The merge panels show an overlap of the FLAG, CALR, and Hoechst 33,258 signal (to reveal the nuclei) at 630X with a close-up view in the right-most panel. (**C**) A bar-graph representation of residual glutathione levels following 60-min incubation of 10 mM glutathione with the indicated concentrations of bacterially expressed wild-type ChaC1, its cysteine free derivative, ChaC1^CtoS^, and its inactive mutant ChaC1^CtoS;E116Q^.**DOI:** [http://dx.doi.org/10.7554/eLife.03421.005](10.7554/eLife.03421.005)10.7554/eLife.03421.006Figure 2---figure supplement 1.Replacement of cysteines with serines circumvents aberrant disulfide bond formation in ER-localized ChaC1.Immunblot of FLAG-tagged authentic, cytosolic mouse ChaC1, ER-localized ChaC1 and ER-localized cysteine-free ChaC1^CtoS^ in lysates of stably-transfected Flp-In T-REx HEK 293T cells expressing the proteins under the control of a tetracycline-inducible promoter. Shown are samples blocked with N-ethyl maleimide at the time of lysis and resolved by reducing and non-reducing SDS-PAGE. Where indicated the cells had been exposed to doxycycline to induce expression of the heterologous protein.**DOI:** [http://dx.doi.org/10.7554/eLife.03421.006](10.7554/eLife.03421.006)

A model of mouse ChaC1, based on the crystal structure of the homologous γ-glutamyl cyclotransferase (PDB 2RBH) ([@bib20]), suggested that none of its four cysteines is likely to play an important role in substrate recognition or catalysis. As expected, conversion of all four cysteines to serines resulted in a protein that no longer formed disulfides when introduced into the ER ([Figure 2A](#fig2){ref-type="fig"}, compare lanes 6 and 7 and [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). Importantly, the cysteine-free enzyme (ChaC1^CtoS^) purified from *E. coli* retained its enzymatic activity ([Figure 2C](#fig2){ref-type="fig"}) and specificity for reduced glutathione ([Figure 1D](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1C](#fig1s1){ref-type="fig"}). There are no predicted N-linked glycosylation sites in ChaC1^CtoS^ to further corrupt protein structure when targeted to the ER, therefore, it seemed possible that ER-localized ChaC1^CtoS^ might retain its enzymatic activity and breakdown glutathione in the ER.

Purging the ER of glutathione {#s2-2}
-----------------------------

Measuring the impact of ER-ChaC1^CtoS^ on glutathione levels required an assay that would be selectively sensitive to the ER pool of glutathione. Glutaredoxin (Grx1) has been shown to dramatically accelerate the interaction of a linked redox-sensitive green fluorescent protein (roGFP) with glutathione, both in vivo and in vitro ([@bib11]; [@bib4]) (cartooned [Figure 3A](#fig3){ref-type="fig"}). We confirmed the reported ability of a linked Grx1 to accelerate the equilibration of roGFP with a glutathione buffer: alone, reduced roGFP2 was only slowly oxidized by glutathione ([Figure 3B](#fig3){ref-type="fig"}), but the linked Grx1 markedly accelerated the oxidation of Grx1-roGFP2 ([Figure 3](#fig3){ref-type="fig"}, compare the red traces in panels B and C). The rate of probe oxidation by glutathione was concentration-dependent, with half-saturation (*Kmax*~*0.5*~) attained at ∼18 µM GSSG ([Figure 3D](#fig3){ref-type="fig"}). Importantly, the presence of oxidized PDI had a minor role in further accelerating the oxidation of Grx1-roGFP2, but dominated the oxidation kinetics of roGFP2 alone ([Figure 3B,C](#fig3){ref-type="fig"}).10.7554/eLife.03421.007Figure 3.ER-targeted ChaC1 purges the organelle of its glutathione content*.*(**A**) Cartoon contrasting the slow coupling of roGFP2 with the glutathione redox buffer (dashed lines) and the rapid coupling of Grx1-roGFP2 with the glutathione redox buffer (after [@bib11]). (**B**) Trace of time-dependent changes in the ratio of reduced to oxidized roGFP2 detected optically as the ratio between the emission signal (at 535 nm) upon excitation at 405 nm vs 488 nm (ex 405/488) following introduction of the fully reduced probe into the indicated solutions of oxidized glutathione (GSSG) or PDI and GSSG. (**C**) Similar trace of reduced Grx1-roGFP2. Note the indifference of roGFP2 and the marked responsiveness of Grx1-roGFP to oxidized glutathione. (**D**) Graph of the initial velocity of Grx1-roGFP2 oxidation as a function of GSSG concentration, fitted to Linweaver--Burk plot. Half-maximal velocity is observed at 18 µM GSSG. (**E**) Trace of time-dependent changes in the ratio of oxidized and reduced roGFP2 and Grx1-roGFP2 probes expressed in the ER of HeLa cells following a brief (1 min) reductive pulse with dithiothreitol (DTT, 2 mM) followed by a washout. (**F**) Bar diagram of the half-time to recovery of oxidized roGFP2 and Grx1-roGFP2 following the reductive DTT pulse. Shown are means ±SD (N = 4, \*p\<0.01). (**G**) Trace of time-dependent changes in the ratio of oxidized to reduced probes expressed in the ER of HeLa cells alongside active or inactive ChaC1 (tagged at its C-terminus with mCherry to allow visualization of cells co-expressing the redox probes and the glutathione-depleting enzyme) following a brief reductive pulse with dithiothreitol and a washout. Note that the expression of active ChaC1 in the ER eliminates the kinetic advantage of Grx1-roGFP2 over roGFP2 in re-oxidation during the recovery from a DTT reductive pulse. (**H**) Bar diagram of the half-time to recovery of oxidized roGFP2 and Grx1-roGFP2 following the reductive DTT pulse in cells co-expressing active or inactive CHaC1. Shown are means ±SEM (N = 20, \*p\<0.01). (**I**) Bar diagram of cellular glutathione levels following 36 hr of doxycycline (DOX) induction of cytosolic and ER localized active and inactive ChaC1 in the absence and presence of concomitant exposure to buthionine-sulfoxide (BSO, 50 µM). Also shown is a time course of total cellular glutathione following induction of active and inactive mCherry-KDEL-tagged ChaC1.**DOI:** [http://dx.doi.org/10.7554/eLife.03421.007](10.7554/eLife.03421.007)

Oxidized glutathione levels recover rapidly following a reductive pulse in cultured mammalian cells ([@bib1]). Therefore, the aforementioned in vitro observations indicating tight coupling of Grx1-roGFP2 to glutathione (and relative indifference to PDI) suggested that the rate of re-oxidation of an ER-localized Grx1-roGFP2 probe following a reductive pulse might be affected by the presence of glutathione in the ER lumen. To examine this further, we first compared the rate of re-oxidation of ER-localized roGFP2 with that of ER-localized Grx1-roGFP2 following a reductive pulse of dithiothreitol (DTT) and its washout. At steady-state both probes were highly oxidized and both were similarly reduced by the DTT pulse. However the recovery of ER-Grx1-roGFP2 was accelerated compared with ER-roGFP2 alone, with a half-time to recovery of 75.3 ± 7.7 s in case of the former and 167.3 ± 16.8 s in case of the latter ([Figure 3E,F](#fig3){ref-type="fig"}). This observation is consistent with a direct contribution of lumenal glutathione to the kinetics of ER-Grx1-roGPF2 re-oxidation in vivo.

Next, we compared the effect of ER-localized enzymatically-active ER-ChaC1^CtoS^ and its catalytically dead counterpart, ER-ChaC1^CtoS−E116Q^ on the rate of oxidation of ER-roGFP2 and ER-Grx1-roGFP2 following a reductive pulse and washout. To focus the measurements on cells co-expressing the roGFP probe and the ChaC1 enzyme, the latter was tagged at its C-terminus with mCherry. Oxidation of ER-roGFP2 was unaffected by the presence of active ChaC1, but the kinetic advantage of ER-Grx1-roGFP2 over the ER-roGFP2 alone was abolished by expression of an active, glutathione-degrading enzyme in the ER lumen ([Figure 3G,H](#fig3){ref-type="fig"}).

We were unable to reproducibly measure glutathione concentrations in microsomal fractions of cultured cells; however, the effect of ChaC1 over-expression on total cellular glutathione was quantifiable. At similar levels of over-expression, cytosolic ChaC1 led to a marked depletion of total cellular glutathione levels, whereas ER-localized ChaC1^CtoS^ had a more modest effect. However, ER-localized ChaC1^CtoS^ markedly enhanced glutathione depletion by low concentrations of buthionine-sulfoxide (BSO, an inhibitor of the rate limiting step of glutathione biosynthesis, [Figure 3I](#fig3){ref-type="fig"}). To avoid the corrupting effect of an untransfected pool of cells, these ensemble measurements were conducted in stable clones homogenously and conditionally-expressing ChaC1 from a doxycycline-inducible transgene. They point to relatively slow equilibration of cytosolic and ER pools of glutathione in mammalian cells. Given that Grx1-roGFP2 reacts with glutathione with a *Kmax*~*0.5*~ in the 10^−5^ M range ([Figure 3D](#fig3){ref-type="fig"}) the effacement of its kinetic advantage over roGFP2 in the DTT washout experiment, indicated a profound and selective depletion of lumenal glutathione by the ER-targeted expression of active ChaC1, with modest effects on other cellular pools of glutathione.

Lumenal glutathione is dispensable to the reductive facets of ER protein folding {#s2-3}
--------------------------------------------------------------------------------

Maturation of the LDL-R in the ER entails significant rearrangement of its 30 disulfide bonds ([@bib17]) and involves the reduced form of the PDI family member ERdj5 ([@bib28]). Maturation of the LDL-R can be tracked by the conversion of the relatively high mobility, glycosylated, ER form, to the lower-mobility post-ER form (reflective of Golgi sugar modifications) in pulse-chase labeling followed by immunoprecipitation. We thus compared the effects of ER expression of active ChaC1^CtoS^ and the catalytically inactive ChaC1^CtoS;E116Q^ mutant on the rate of maturation of co-expressed LDL-R tagged on its C-terminal, cytosolic facing domain, with a triple FLAG-tag.

Conversion of the LDL-R from its ER to post-ER form was unaffected by the presence of either active or inactive form of ER-ChaC1 and proceeded with a half-life of ∼1 hr in presence or absence of an active glutathione-depleting enzyme in the ER ([Figure 4A](#fig4){ref-type="fig"}). The non-reducing gel revealed identical accelerated mobility of LDL-R at the earliest time point, regardless of expression of ChaC1, indicating that glutathione depletion also had no drastic effect on the earlier oxidative phase of LDL-R maturation ([Figure 4A,B](#fig4){ref-type="fig"}).10.7554/eLife.03421.008Figure 4.Maturation of the LDL-R receptor is unaffected by depletion of ER glutathione.(**A**) Autoradiograph of metabolically labeled LDL receptor (LDL-R) immunopurified from HeLa cells co-expressing the FLAG-tagged LDL-R and ER-localized enzymatically active (ER-ChaC1^CtoS^) or inactive ChaC1 (ER-ChaC1^CtoS;E116Q^) and resolved on a reducing SDS-PAGE. Cells were lysed at the end of a 30-min labeling pulse (lanes 1 and 6) or after an additional chase period (indicated). The mobility of the ER and Golgi forms of the LDL-R on reducing (left) and non-reducing (right) SDS-PAGE is indicated, as is the labeled ChaC1, which is also recovered in this anti-FLAG immunoprecipitation. (**B**) Graphic presentation of the conversion of the ER to Golgi form of the LDL-R from '**A**' above. Shown is a representative experiment reproduce three times with similar outcome. (**C**) Autoradiograph of an experiment similar in layout to that depicted in '**A**' above. Where indicated, the cells were exposed to the glutathione synthesis inhibitor buthionine-sulfoxide (BSO, 100 µM, 20 hr) before the pulse-chase labeling. (**D**) Graphic presentation of the conversion of the ER to Golgi form of the LDL-R from '**C**' above. Shown is a representative experiment reproduce three times with similar outcome. (**E**) Bar graph of total cellular glutathione in cells manipulated as in the experiment described in '**C**' (shown is the mean ±SD, n = 3, \*p\<0.05). (**F**) Trace of time-dependent changes in the ratio of oxidized and reduced roGFP2 expressed in the ER of mouse embryonic fibroblasts with genetic lesions compromising disulfide bond formation (Ero1a^m/m^; Ero1b^m/m^; Prdx4^m/y^) following a brief reductive pulse with dithiothreitol followed by a washout. The cells co-expressed ER-localized enzymatically active (ER-ChaC1^CtoS^) or inactive ChaC1 (ER-ChaC1^CtoS;E116Q^) marked at its C-terminus with an mCherry fluorescent probe. (**G**) Bar diagram of the half-time to recovery of oxidized roGFP2 following the reductive DTT pulse in '**F**' above. Note that expression of active ChaC1 in the ER did not affect the rate of recovery of the sentinel disulfide in ER-localized roGFP2.**DOI:** [http://dx.doi.org/10.7554/eLife.03421.008](10.7554/eLife.03421.008)

LDL-R maturation was also unaffected by further global depletion of cellular glutathione, effected by the combined expression of ER-ChaC1^CtoS^ and exposure to buthionine sulfoxide (BSO), which depleted glutathione globally ([Figure 4C--E](#fig4){ref-type="fig"}). These experiments, conducted in HeLa cells, where reductive editing of LDL-R disulfides was first discovered ([@bib17]), reinforces the dispensability of glutathione to that process.

To further explore the potential role of ER glutathione in the early oxidative steps of protein folding, we used highly sensitized mouse cells genetically deficient in the upstream thiol oxidases ERO1 and PRDX4 ([@bib41], [@bib40]) Expression of active ChaC1 in their ER had no effect on the kinetics of disulfide re-formation on ER-localized roGFP2 following a reductive DTT pulse ([Figure 4F--G](#fig4){ref-type="fig"}), further attesting to the dispensability of glutathione to thiol oxidation in the mammalian ER.

The degradation of misfolded NHK-A1AT requires the action of the reduced form of a specialized PDI, ERdj5 ([@bib36]; [@bib12]). To determine if an ER pool of glutathione contributes to this process, we compared the half-life of C-terminally FLAG-tagged NHK-A1AT in cells expressing active ER-ChaC1^CtoS^ and the catalytically inactive ER-ChaC1^CtoS;E116Q^. The stability of NHK-A1AT was unaffected by ChaC1 both in HeLa cells ([Figure 5A,D](#fig5){ref-type="fig"}) and in 293T cells ([Figure 5B,E](#fig5){ref-type="fig"}). Furthermore, depletion of total cellular pools of glutathione by coincidental exposure to BSO had no effect on NHK-A1AT half-life ([Figure 5C,F](#fig5){ref-type="fig"}), complementing the evidence for the dispensability of glutathione for ER-associated degradation of this redox-dependent substrate.10.7554/eLife.03421.009Figure 5.Clearance of misfolded null Hong Kong mutant alpha 1 anti-trypsin (NHK-A1AT) is unaffected by depletion of ER glutathione.(**A**) Autoradiograph of metabolically labeled NHK-A1AT immunopurified from HeLa cells co-expressing C-terminally FLAG-tagged NHK-A1AT and ER-localized enzymatically active (ER-ChaC1^CtoS^) or inactive ChaC1 (ER-ChaC1^CtoS;E116Q^) and resolved on a reducing or non-reducing SDS-PAGE. Cells were lysed at the end of a 30-min labeling pulse (lanes 1 and 5) or after an additional chase period (indicated). The mobility of the labeled NHK-A1AT, and the ER-chaperone BiP that co-purifies with it, are indicated, as is the labeled ChaC1, which is also recovered in this anti-FLAG immunoprecipitate. (**B**) Autoradiograph of samples recovered from 293T cells in an experimental design as in '**A**'. (**C**) Autoradiograph of samples recovered from HeLa cells in an experimental design as in '**A**'. Where indicated, cells were exposed to the glutathione synthesis inhibitor buthionine-sulfoxide (BSO, 100 µM, 20 hr) before the pulse-chase labeling. (**D**--**F**) Plot of time-dependent change in NHK-A1AT (monomer) signal from the reducing gels **A**--**C** above. Shown are representative experiments reproduced twice with similar outcome.**DOI:** [http://dx.doi.org/10.7554/eLife.03421.009](10.7554/eLife.03421.009)

Thiol redox reactions contribute to protein folding homeostasis in the endoplasmic reticulum. This is reflected in enhanced signaling in the endoplasmic reticulum unfolded protein response (UPR) in cells impaired in ER thiol redox ([@bib9]; [@bib29]). Therefore, to gain a more global view on the impact of ER glutathione depletion on ER protein folding homeostasis, we compared the effect on UPR activity of ER-targeted active and inactive ChaC1. These experiments made use of mCherry-tagged ChaC1^CtoS^, which retains its enzymatic activity, purges the ER of glutathione ([Figures 1D and 3G](#fig1 fig3){ref-type="fig"}) and marks the ChaC1-expressing cells.

Dual-channel FACS analysis revealed that neither active nor inactive ER-ChaC1^CtoS^-mCherry-KDEL measurably affected the basal activity of a stably integrated mammalian UPR reporter, CHOP::GFP ([@bib27]) (reflected in the absence of a shift to the right in the mCherry positive population of cells, [Figure 6A](#fig6){ref-type="fig"}, left column). Furthermore, the activity of the CHOP::GFP reporter, which was increased by tunicamycin, a toxin that perturbs protein folding homeostasis in the ER, was unaffected by ChaC1 ([Figure 6A](#fig6){ref-type="fig"}). The indifference of the UPR to ER-ChaC1^CtoS^ is observed over a broad range of unfolded protein stress and over a broad range of ER-ChaC1^CtoS^-mCherry-KDEL expression, and suggests that the lesson learned from the sentinel proteins, LDL-R and NHK-A1AT likely extend to the bulk of proteins that fold oxidatively in the ER under normal cell culture conditions.10.7554/eLife.03421.010Figure 6.Activity of the unfolded protein response (UPR) is unaffected by depletion of ER glutathione.(**A**) Two-dimensional plots (FACScans) of fluorescent intensity of individual CHO cells containing a stably-integrated UPR reporter, CHOP::GFP ([@bib27]), following transfection with plasmids encoding ER-localized, active (ER-ChaC1^CtoS^-mCherry-KDEL) or inactive ChaC1 (ER-ChaC1^CtoS;E116Q^-mCherry-KDEL). GFP fluorescent intensity, reporting on the activity of the UPR (X-axis), was detected at 530 ± 30 nm following excitation at 488 nm, whereas mCherry fluorescent intensity, reporting on the level of ChaC1-mCherry-KDEL in the ER (Y axis), was detected at 610 ± 20 nm following excitation at 561 nm. Where indicated the cells were exposed to the ER stress-inducing agent tunicamycin for the indicated period of time. (**B**) Three-color FACScans as in '**A**' of CHOP::GFP cells co-transfected with expression plasmids for a hyperactive mutant of ERO1 (C104A, C133A; ERO1\*) tagged by the cell-surface marker CD2 (decorated with an AF647-tagged antibody and detected by excitation at 640 nm and emission at 670 nm) with a wildtype or inactive mutants of ChaC1 fused to mCherry, as noted above. The axis of the scans are labeled with the cognate signals and panels numbered for ease of reference in the text.**DOI:** [http://dx.doi.org/10.7554/eLife.03421.010](10.7554/eLife.03421.010)10.7554/eLife.03421.011Figure 6---figure supplement 1.Activity of the unfolded protein response (UPR) as measured by an XBP1-splicing reporter is also unaffected by depletion of ER glutathione.FACScans as in '6B' of CHO cells stably transduced with an XBP1 splicing reporter linked to the expression of the fluorescent protein Venus ([@bib16]). Where indicated cells were co-transfected with expression plasmids for a hyperactive mutant of ERO1 (C104A, C133A; ERO1\*) tagged by the cell-surface marker CD2 and wild-type or inactive mutants of ChaC1 fused to mCherry. The axis of the scans is labeled with the cognate signals.**DOI:** [http://dx.doi.org/10.7554/eLife.03421.011](10.7554/eLife.03421.011)

The role of ER glutathione was further explored under conditions in which ER redox balance was perturbed by co-expression of a deregulated allele of the ER oxidase ERO1 ([@bib33]), which has been shown to hyper-oxidize the mammalian ER ([@bib3]) and modestly activate the UPR ([@bib13]). Introduction of the C104A; C133A human ERO1L (ERO1\*), expressed from a plasmid tagged with the CD2 surface marker indeed modestly activated the UPR, whether measured in cells stably expressing the CHOP::GFP transcriptional reporter ([Figure 6B](#fig6){ref-type="fig"}, reflected in the higher GFP levels of cells co-expressing the CD2 marker which tags the ERO1\*-expressing cells, panels 2, 4, and 7) or an XBP1::Venus splicing reporter ([@bib16]) ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). However, co-expression of active ChaC1^CtoS^ had no evident synergistic effect with ERO1\* on UPR activity beyond that observed with the enzymatically inactive E116Q mutant enzyme. This is evident by first noting that in this co-transfection experiment most ERO1\* expressing cells (CD2 positive) are also co-expressing the Cherry-tagged ChaC1^CtoS^ ([Figure 6B](#fig6){ref-type="fig"}, panels 3 and 6) and then noting that the relationship between ERO1\* expression (for which CD2 is a surrogate) and the CHOP::GFP signal is indistinguishable in cells co-expressing wild-type and enzymatically inactive ChaC1^CtoS^ ([Figure 6B](#fig6){ref-type="fig"} panels 4 and 7). Similarly, the co-expression of ERO1\* does not impart sensitivity to active ChaC1, as reflected by the observation that CHOP::GFP levels are unaffected by ChaC1^CtoS^ in these double positive cells ([Figure 6B](#fig6){ref-type="fig"} panels 5 and 8). These findings indicate that glutathione is dispensable for the function of the ER even under hyperoxidizing conditions.

Discussion {#s3}
==========

Adapting a cytosolic enzyme that breaks down glutathione to function in the ER has afforded a means to selectively purge the organelle of glutathione and thereby assess the role of this otherwise abundant tri-peptide in ER protein redox. Nearly complete depletion of ER glutathione had no measurable effect on the rate of disulfide bond formation in the highly sensitized experimental setting of cells deficient in ER thiol oxidases. More surprising was the lack of any measurable effect of glutathione depletion on processes that require a pool of reduced PDI enzymes: the disulfide shuffling-dependent maturation of nascent LDL-R and the degradation of a folding incompetent mutant NHK-A1AT. Furthermore, depletion of ER glutathione was without effect on two sensitive, broad-spectrum UPR reporters, arguing that glutathione is indeed dispensable to a broad range of processes required for protein folding homeostasis in the ER of cultured mammalian cells.

The dispensability of glutathione to reductive processes in the ER has been hinted at previously: in yeast deletion of *GSH1* (encoding gamma glutamylcysteine synthetase that performs the rate-limiting step in glutathione biosynthesis) does not adversely affect the maturation of the disulfide-bonded lysosomal hydrolyze CPY ([@bib9]). However, the extent of ER glutathione depletion attained by this genetic manipulation is unclear and, given the essential role of cellular glutathione to yeast growth, may have been limited by toxicity. Similar reservations apply to the use of enzyme inhibitors, such as BSO, which subject the cell to the consequences of glutathione depletion in other compartments where it has an essential role ([@bib21]), but whose effect on the ER pools of glutathione may be partial.

How complete was depletion of ER glutathione by ChaC1? In vitro the re-oxidation of Grx1-roGFP2 is half-maximal at 18 µM glutathione ([Figure 3D](#fig3){ref-type="fig"}). Thus, the abolition of the kinetic advantage of Grx1-roGFP2 over roGFP2 in cells expressing enzymatically active ChaC1 argues that, despite the enzyme\'s relative low affinity for its substrate (in the millimolar range, [@bib20]; and [Figure 1---figure supplement 1C,D](#fig1s1){ref-type="fig"}), glutathione levels were purged to micromolar levels by the high concentration of the enzyme. This conclusion is also supported by the effects of ER ChaC1 on total cellular glutathione levels: At similar levels of expression, cytosolic ChaC1 led to near complete depletion of total cellular glutathione, whereas ER ChaC1 had a more modest effect on total cellular pools. Given the 10-fold greater volume of the cytosol over the ER ([@bib34]), the aforementioned observations indicate substantially higher local concentration of ER vs cytosolic ChaC1. Thus, the preservation of total cellular glutathione levels in cells expressing high levels of ChaC1 in their ER confirms that transport of glutathione into the ER, from its site of synthesis in the cytosol, is slow (as suggested by [@bib21]), and therefore, that depletion of ER stores by ChaC1 is profound.

The redundancy of glutathione could be explained by other small molecule thiols fueling reduction in the ER. These may even include cysteinyl-glycine, one of the glutathione breakdown product of ChaC1 action. Alternatively, eukaryotes may have a protein-driven apparatus akin to bacterial DsbD for ferrying reducing equivalents from the cytosol to reduce PDI family members.

Despite its apparent dispensability, ER glutathione does equilibrate with protein thiols ([@bib1]), indicating that it is a redox buffer in the organelle. However, it is possible that despite seemingly rapid equilibration of glutathione to protein thiol redox, the kinetics are insufficient to render glutathione essential and that other, even faster processes, maintain an adequate pool of reduced and oxidized PDIs in the mammalian ER, with glutathione following passively. It is noteworthy, in this vein, that ERO1-deficient cells, with compromised ER thiol oxidative power, have an elevated ratio of oxidized to reduced glutathione ([@bib1]; [@bib30]). It has been speculated, reasonably, that this reflects the action of an alternative oxidative pathway that kicks-in when the major oxidases are compromised and exploits oxidized glutathione to couple to protein thiol oxidation. However, our finding that ER glutathione depletion does not further compromise protein thiol oxidation kinetics in oxidase-deficient cells suggests that here too glutathione follows passively the rearrangements in redox pathways and does not participate actively in their implementation.

Across distant phyla, ER redox is not indifferent to cellular glutathione levels. Depletion of glutathione, by *GSH1* deletion, rescues the oxidative defect in ERO1-deficient yeast ([@bib7]), and cytosolic glutathione influences disulfide-bonding of glutenin in the ER of wheat endosperm ([@bib23]). These observations, which fall short of directly indicting glutathione in reducing ER disulfides, nonetheless argue for participation of glutathione in a shared economy of reducing equivalents across the ER membrane. Prolonged (48 hr) depletion of glutathione by high concentrations of BSO (1 mM) synergize with ER hyperoxidation to degrade cell viability ([@bib13]). Further support for the idea of a shared economy of glutathione is provided by the phenotype of yeast over-expressing a plasma membrane glutathione transporter HGT1. Glutathione over-load in these cells compromises protein folding in the ER and triggers an unfolded protein response, the basis of which appears to be unregulated re-cycling of PDI from its oxidized to its reduced state imposed by the excessive glutathione ([@bib21]). While our state of ignorance in regard to the genes responsible for glutathione transport into the yeast ER preclude assigning a role to luminal glutathione in this consequences of cellular glutathione overload, the observations of Kumar et al. clearly argue that glutathione may participate in ER redox.

In mammalian cells too, glutathione stands to impact the maturation of some secreted or membrane proteins: In a study agnostic of its enzymatic activity, over-expression of wild-type cytosolic ChaC1 in mouse ganglionic eminence cells profoundly inhibited the maturation of the Notch precursor to its furin-cleaved form ([@bib5]). Whereas anti-oxidants that restore impaired glutathione metabolism to normality have been shown to improve the capacity of liver cells to secrete factor VIII, a heavily disulfide bonded serum protein ([@bib25]). Thus, conservatively interpreted, our observations lead to the conclusion that ER glutathione is not generally required to maintain protein thiol redox nor folding homeostasis in the ER of cultured mammalian cells. It may now be informative to examine the impact of an ER glutathione purge elicited by ER-localized ChaC1^CtoS^ on the fate of specialized secretory cells and their specialized secretory cargo proteins.

Materials and methods {#s4}
=====================

Plasmid construction {#s4-1}
--------------------

[Table 1](#tbl1){ref-type="table"} lists the plasmids used, their lab names, description, published reference, and a notation of their appearance in the figures.10.7554/eLife.03421.014Table 1.List of the plasmids used in this study, their unique lab identifier, lab name, description, PMID of the relevant reference (if available), figure in which they first appear and cognate label in figure legend**DOI:** [http://dx.doi.org/10.7554/eLife.03421.014](10.7554/eLife.03421.014)IDPlasmid nameDescriptionReferenceFirst appearanceLabel in figure15pFLAG-CMV1Mammalian expression bovine trypsinogen signal peptide-FLAGM1 fusionPMID: 80247962AER-FLAG_vector242roGFP2_pRSETBBacterial expression of 6X His-tagged roGFP2PMID: 147220623AroGFP2836mChac1_1-224-H6-pET30aBacterial expression of mouse Chac1 C-terminal His-taggedThis paper1AChaC1888pFLAG_mCherry_KDEL_CMV1ER localised FLAGM1-mCherry-KDEL in pFLAG-CMV1This paper6AER-vector915mChaC1_1-224_CtoS_pET30aBacterial expression mouse Chac1 CtoS (C92S, C169S, C190S, C212S) C-terminal His-taggedThis paper2CChaC1_CtoS932mChaC1_1-224_E116Q_pET30aBacterial expression of E116Q mutant mouse Chac1 C-terminal His-taggedThis paper1EChaC1_E116Q934mChaC1_3XFLAG_pCDNA5_FRT_TOMammalian expression of C-term FLAG-tagged mouse ChaC1This paper3HCyto-ChaC1937mChaC1_CtoS_E116_pET30aBacterial expression of E116Q cysteine to serine mutant mouse Chac1 C-terminal His-taggedThis paper2CChaC1_CtoS_E116Q945mChaC1_E116Q_3XFLAG_pCDNA5_FRT_TOMammalian expression of C-term FLAG-tagged mouse ChaC1 E116Q mutant (Cyto-ChaC1_E116Q)This paper3HCyto-ChaC1_E116Q950FLAGM1_mChaC1_CtoS_pCDNA5_FRT_TOMammalian expression ER-localised FLAG M1 tagged mouse CHAC1 CtoS (C92S, C169S, C190S, C212S) KDELThis paper2AER-FLAG_ChaC1_CtoS951FLAGM1_mChaC1_CtoS_E116Q_pCDNA5_FRT_TOMammalian expression ER-localised FLAG M1 tagged mouse CHAC1 CtoS (C92S, C169S, C190S, C212S) E116Q KDELThis paper2AER-FLAG_ChaC1_CtoS_E116Q974FLAGM1_mChaC1_WT_pCDNA5_FRT_TOMammalian expression ER-localised FLAG M1 tagged mouse CHAC1 KDELThis paper2AER-FLAG_ChaC1988FLAGM1_mChaC1_CtoS_mCherry_pCDNA5_FRT_TOMammalian expression ER-localised FLAG M1 tagged mouse CHAC1 mCherry-KDEL, CtoS (C92S, C169S, C190S, C212S)This paper3FER-ChaC1_CtoS_mCherry993mChaC1_CtoS_92C_mCherry-pET30aBacterial expression of mouse ChaC1-mCherry fusion, C-terminal His-tagged, (C169S, C190S, C212S)This paper1DOG-ChaC1-Cherry probe1028FLAGM1_mChaC1_CtoS_E116Q_mCherry_pCDNA5Mammalian expression ER-localised FLAG M1 tagged mouse CHAC1 mCherry-KDEL, CtoS, E116QThis paper3FER-ChaC1_CtoS_E116Q_mCherry1037mChaC1_CtoS_S92C_E116Q_mCherry-pET30aBacterial expression of mouse ChaC1-mCherry fusion, C-terminal His-tagged, (C169S, C190S, C212S), E116QThis paperS1COG-ChaC1_E116Q-Cherry1052ER_roGFP2_pCDNA3.1ER localized roGFP2 KDELThis paper3DER-roGFP21063ER_Grx1_roGFP2_KDEL_pCDNA3.1ER localized Grx1 fused to roGFP2 KDELPMID:234241943DER-Grx1-roGFP21181hLDLR_3XFLAG_pCDNA5_FRTMammalian expression plasmid of human LDL receptor, cytosolic tail tagged with a 3X FLAG tagPMID:124939184AFLAG-tagged LDL-R1204A1AT_NHK_3XFLAG_pCDNA5_FRT_TOMammalian expression plasmid of null Hong-Kong mutant a1-antitrypsin C-terminally tagged with 3XFLAGPMID:127362545AFLAG-tagged NHK-A1AT1206Grx1_roGFP2_pET30aBacterial expression of Grx1-roGFP2 fusion proteinPMID: 184698223BGrx1-roGFP21239pCAX-F-XBP1ΔDBD-venusXBP1 mini-cDNA with Venus fused the post-IRE1 spliced open reading framePMID: 147026396CXBP1-Venus1273hERO1A_C104A_C131A_pCDNA3-CD2Mammalian expression plasmid encoding human hyperactive ERO1L (ERO1a) and a co-expressed human CD2 FACS markerPMID: 230278706BERO1\*

The mouse ChaC1 cDNA (IMAGE clone 4483043) was purchased from Source Bioscience. Bacterial expression vectors encoding C-terminally His 6X tagged wild type and E116Q mutant ChaC1 were constructed by PCR amplification. A mutant ChaC1 in which all four cysteines were converted to serines, CtoS (C92S, C169S, C190S, C212S), was synthesized as an artificial gene and shuttled into the mammalian and bacterial expression plasmids described in [Table 1](#tbl1){ref-type="table"}.

Bacterial expression plasmids for roGFP2 ([@bib14]) and the glutaredoxin 1 fusion to roGFP2 ([@bib11]) were gifts of James Remington (U Oregon) and Tobias Dick (DKFZ, Heidelebrg). ER localized mammalian expression plasmids of their counterparts were generated by deleting the E147b insertion and introducing an S65T mutation into ER_HA_Grx1_roGFP1iE_KDEL_pcDNA3.1 ([@bib4]) (a gift of Christian Appenzeller-Herzog, University of Basel). ER_roGFP2 was produced by deleting E147b from FLAGM1_roGFP2_iE_pCDNA3.1 ([@bib2]).

Mammalian expression plasmids encoding ER localized FLAG M1-tagged ChaC1 with a KDEL ER retention signal at the C-terminus and mutant derivatives thereof were constructed by shuttling the ChaC1 coding sequence into the relevant plasmid backbone. Mammalian expression plasmids for ER-localized ChaC1 fused to the mCherry fluorescent protein were prepared using similar techniques.

The hyperactive C104A: C133A allele of human ERO1L (ERO1A) was expressed from a modified pCDNA3 plasmid in which the coding sequence of the Neo^r^ marker had been replaced by human CD2.

Protein purification and in vitro enzymatic assays {#s4-2}
--------------------------------------------------

C-terminally 6X His-tagged mouse ChaC1 was expressed in BL21 pLysS *E. coli* at 30°C with 4 hr of induction with 1 mM IPTG and purified from the lysate by nickel affinity chromatography followed by size exclusion chromatography on Superdex 200 (GE Healthcare, Chalfont St Giles, United Kingdom) in 20 mM Tris pH7.4, 100 mM NaCl, 10% Glycerol, 1 mM Tris(2-carboxyethyl)phosphine hydrochloride (TCEP).

Glutathione degradation by purified wild-type ChaC1 and its mutant derivatives was assayed using the 5,5′-dithiobis-(2-nitrobenzoic acid) (DTNB) recycling assay of [@bib35] as modified by [@bib10].

Mutant ChaC1 (C169S, C190S, C212S) fused at its C-terminus to an mCherry 6X His fluorescent protein was purified from *E. coli* and labeled at its single remaining cysteine (C92) with thiol reactive Oregon Green 488 iodoacetamide (Life Technologies), according to the manufacturer\'s instructions.

Fluorescent resonance energy transfer (FRET) between the Oregon Green donor and the mCherry acceptor was measured at room temperature on TECAN 500 plate reader as the ratio between their fluorescence emission at 535 nm and 670 nm respectively when they were excited at 485 nm and 590 nm. The binding reaction was initiated by addition of reduced glutathione (G4251, Sigma) or oxidized glutathione (G4626, Sigma).

Human PDI (PDIA1 18--508) and roGFP variants were expressed in the *E. coli* BL21 (DE3) strain, purified with Ni-NTA affinity chromatography, dialyzed into the reaction buffer, reduced by incubation with 20 mM of DTT, and then buffer exchanged on a PD-10 gel filtration column (GE Healthcare), as described previously ([@bib2]).

Reduced PDI (5 μM) was equilibrated in 100 mM Tris--HCl, 150 mM NaCl, pH 7.5 degassed buffer before being added to samples containing roGFP variants in the reduced state followed by oxidized glutathione (100 μM; Sigma). The ratio of fluorescence emission at 535 nm of samples sequentially excited at 405 nm and 488 nm was measured using a Synergy 4 microplate reader (BioTek Instruments). Kinetic parameters were extracted by fitting the data to a Linweaver--Burk plot.

Cell culture, transfection {#s4-3}
--------------------------

HeLa and HEK293T cells were cultured in DMEM supplemented with 10% FBS and maintained at 37°C with 5% CO~2~. Cells were electroporated with the indicated plasmids (5 μg of DNA/1 × 10^6^ cells) utilizing the Neon transfection system or Lipofectamine LTX (both from Life Technologies) following the manufacturer\'s protocols.

The effects of cytosolic and ER-localized ChaC1 on cellular glutathione pools were analyzed in stable clones of doxycycline-inducible Flp-In™ T-REx™ HEK 293T cells by the 5,5′-dithiobis-(2-nitrobenzoic acid) (DTNB) recycling assay of [@bib35] as modified by [@bib10].

The effects of ChaC1 on the activity of the unfolded protein response were studied by transient transfection of stable CHOP::GFP reporter Chinese Hamster Ovary cells (C30 clone of CHO K1 cells \[[@bib27]\]) or a stable clone of CHO K1 cells (XV8-1) expressing a Venus reporter of XBP1 splicing activity ([@bib16]) followed by multi-channel FACS analysis on an LSRFortessa (BD Bioscience) of the GFP or Venus signals, which reports on the intensity of the unfolded protein response and mCherry expression that reports on the level of expression of ER localized ChaC1. Where indicated, a CD2-marked expression plasmid encoding a hyper-active mutant of human ERO1L (C104A; C133A, [@bib13]) or CD2-marked empty vector was co-transfected and CD2 expression detected by surface staining with an AlexaFluor 647 conjugated mouse anti-human CD2 antibody, clone LT2 (MCA1194A647, AbD Serotec/Biorad).

Immunoblot analysis {#s4-4}
-------------------

24 hr after transfection, cells were washed twice with PBS and lysed for 30 min on ice in 1% Triton X-100, 20 mM Tris--HCl (pH 7.4), 150 mM NaCl, 1 mM EDTA, 0.1 mM PMSF, 3--7 TIU/L aprotinin, and 20 mM N-ethylmaleimide (NEM). The cellular lysate was centrifuged at 15,000 ×*g* for 15 min, and the supernatant was used for protein assay using a BCA protein assay reagent. Total proteins (30 μg) were separated on 12% SDS--polyacrylamide gels and electroblotted onto PVDF membrane. Primary antibodies to the FLAG tag (Sigma Cat \#F1804, 1:1000 dilution) or a rabbit antiserum to bacterially expressed H6-tagged mouse ChaC1 (residues 1--224, lab number UC8166, 1:1000 dilution) followed by IR800 conjugated secondary antibody and by scanning on a Licor Odyssey scanner.

Immunofluorescence {#s4-5}
------------------

Transfected HeLa cells were grown on coverslips. 24 hr after transfection, the cells were washed with PBS, fixed with 4% paraformaldehyde for 30 min at room temperature, permeabilized in PBS containing 0.1% Triton X-100 for 30 min at room temperature, and blocked in 1% BSA in PBS for 30 min at room temperature. Anti-FLAG antibodies (1:1000 dilution in PBS) in combination with rabbit anti-calreticulin antibodies (a gift of Steven High, University of Manchester, 1:1000 dilution in PBS) followed by goat anti-mouse and goat anti-rabbit secondary antibodies conjugated with DyLight 543 and DyLight 488 (1:1000 dilution in PBS, Jackson ImmunoResearch Laboratories), respectively. Nuclei were counter stained with Hoechst 33,342 (2 μg/ml in PBS) for 30 min at room temperature for counter-staining.

Confocal microscopy {#s4-6}
-------------------

Cells co-transfected with the redox reporter (roGFP) and ChaC1-mCherry were analyzed by laser-scanning confocal microscopy system (510 Meta; Carl Zeiss) with a Plan-Apo- chromat 63× oil immersion lens (NA 1.4), coupled to a microscope incubator, maintaining standard tissue culture conditions (Okolab). Fluorescence ratiometric intensity images (512 × 512 points, 16 bit) of live cells were acquired. A diode 405 nm and Argon 488 nm lasers (2 and 0.5% output respectively) were used for excitation of the ratiometric probes in the multitrack mode with an HFT 488/405 beam splitter, the signal was detected with 518--550 nm filters, the detector gain was arbitrary adjusted to yield an intensity ratio of the two channels approximating one.

The recovery half-time was extracted from fitting the intensity ratio changes over time to an exponential equation $\mathbf{~I}\left( \mathbf{t} \right) = \mathbf{A}\left( 1 - \mathbf{e}^{- \mathbf{\tau t}} \right)$, where I is intensity, t is time, τ is recovery half-time.

Metabolic labeling and pulse-chase analysis {#s4-7}
-------------------------------------------

Cells were co-transfected with ER_mChaC1 and the FLAG-tagged LDL receptor or mutant alpha1 antitrypsin NHK plasmids. 24 hr later, pulse-chase labeled, followed by anti-FLAG immunoprecipitation (Sigma A2220), SDS-PAGE and autoradiography were conducted as previously described ([@bib39]). Where indicated, the glutathione synthesis inhibitor buthionine-sulfoxide (BSO, 100 µM, 20 hr) was added before the pulse-chase labeling. Purified protein intensities were quantified using ImageJ software. Images of gels were scaled to fit the page dimensions.
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eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see [review process](http://elifesciences.org/review-process)). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.

Thank you for sending your work entitled "Intact protein folding in the glutathione-depleted endoplasmic reticulum implicates alternative protein thiol reductants" for consideration at *eLife*. Your article has been favorably evaluated by Vivek Malhotra (Senior editor) and 3 reviewers, one of whom is a member of our Board of Reviewing Editors.

The Reviewing editor and the other reviewers discussed their comments before we reached this decision, and the Reviewing editor has assembled the following comments to help you prepare a revised submission.

It is widely accepted that reduced glutathione in the ER is the primary driver of the disulfide reduction needed for thiol editing as proteins mature. This paper uses an elegant approach to test this assumption directly. By expressing specifically in the ER a glutathione-degrading enzyme the authors assess the effect on various well established assays of folding, maturation and quality control. Surprisingly, none of the processes examined were affected by the loss of glutathione.

This represents a radical challenge to the current models. The experiments are thorough and carefully controlled. The authors discuss the implications carefully and quite conservatively but are forced to conclude that the presence of a glutathione-driven enzyme system in the ER lumen is not necessary for at least much of the protein folding and redox homeostasis in this organelle.

All three reviewers found this paper to be provocative, well done, and rigorous. The data are of outstanding quality, and they are succinctly and clearly described and discussed. There was a clear consensus that it was appropriate for *eLife* with some relatively minor amendments, outlined below.

The experiments and controls are logical but some of them are quite complex. Diagrams of the experimental logic might help in some cases.

Nomenclature should be standardized. Glutathione vs. GSSG vs. tripeptide (the latter being a bit jargony, unless explained). When [Figure 6A](#fig6){ref-type="fig"} is described in the text the ER-ChaC1-CtoS has lost the \'CtoS\'.

Related to the data in [Figure 6](#fig6){ref-type="fig"}, depletion of total cellular glutathione with BSO has been described previously as aggravating the toxicity of ERO1\* ([@bib13]). The authors should offer some discussion as to how this prior observation can be reconciled with their conclusion that ER-ChaC1 has no impact on ER homeostasis in cells expressing ERO1\* as measured by UPR induction.

It would be helpful to further explain the FACScans in [Figure 6](#fig6){ref-type="fig"}. For example, a few basic sentences of explanation such as "a shift to the right for the GFP signal depicts UPR induction" would be helpful. In addition, what do the boxes denote in [Figure 6A](#fig6){ref-type="fig"}?
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Author response

*The experiments and controls are logical but some of them are quite complex. Diagrams of the experimental logic might help in some cases*.

To help guide the reader through some of the less obvious experiments, we have revised the text to provide clear predictions on the correspondence between hypothesis and results. Furthermore, we have introduced a new panel into [Figure 3](#fig3){ref-type="fig"} (panel A) cartooning the different kinetic coupling of the two redox probes (roGFP2 and Grx1-roGFP2) with the glutathione buffer.

*Nomenclature should be standardized. Glutathione vs. GSSG vs. tripeptide (the latter being a bit jargony, unless explained). When* [*Figure 6A*](#fig6){ref-type="fig"} *is described in the text the ER-ChaC1-CtoS has lost the \'CtoS\'*.

Glutathione is now uniformly referred to as such.

*Related to the data in* [*Figure 6*](#fig6){ref-type="fig"}*, depletion of total cellular glutathione with BSO has been described previously as aggravating the toxicity of ERO1\* (*[@bib13]*). The authors should offer some discussion as to how this prior observation can be reconciled with their conclusion that ER-ChaC1 has no impact on ER homeostasis in cells expressing ERO1\* as measured by UPR induction*.

We thank the reviewers for alerting us to the need to address this issue. In the revised version the Discussion cites Hansen's findings and places them in context with ours.

*It would be helpful to further explain the FACScans in* [*Figure 6*](#fig6){ref-type="fig"}*. For example, a few basic sentences of explanation such as "a shift to the right for the GFP signal depicts UPR induction" would be helpful. In addition, what do the boxes denote in* [*Figure 6A*](#fig6){ref-type="fig"}?

The explanation of the FACScan has been expanded. The unhelpful boxes were removed.
